ProCE Banner Activity

Express Points
AL Amyloidosis: Advances in Early Diagnosis, Treatment Options, and Individualized Care

Slideset Download
Downloadable summary slideset on the key takeaways from a live symposium on diagnosing and typing AL amyloidosis, and managing newly diagnosed and relapsed/refractory disease.

Released: December 16, 2022

Expiration: December 15, 2023

No longer available for credit.

Share

Faculty

Angela Dispenzieri

Angela Dispenzieri, MD

Consultant
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine 
Mayo Clinic
Rochester, Minnesota 

Anita D Souza

Anita D Souza, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Attending Physician
Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin

Jeffrey Zonder

Jeffrey Zonder, MD

Professor of Oncology  
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Alexion Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Program Director Disclosure

Program Director

Angela Dispenzieri, MD

Consultant
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine 
Mayo Clinic
Rochester, Minnesota 

Faculty Disclosure

Primary Author

Anita D Souza, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Medical College of Wisconsin
Attending Physician
Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin

Anita D’Souza, MD: consultant/advisor/speaker: Bristol-Myers Squibb, Janssen, Prothena; researcher: AbbVie, Caelum, Janssen, Prothena, Regeneron, Sanofi, Takeda, TeneoBio.

Jeffrey Zonder, MD

Professor of Oncology  
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Jeffrey Zonder, MD: consultant/advisor/speaker: Caelum/AstraZeneca, Intellia, Janssen, Prothena, Regeneron, Takeda; researcher: Bristol-Myers Squib